Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kellie Schoolar Reynolds

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|February 9, 2018
Breaking Down Barriers to Effective Patient CarePeter H O'Donnell, Kellie Schoolar Reynolds
Current Opinion in HIV and AIDS|April 18, 2009
A regulatory perspective on the role of drug interactions in antiretroviral drug developmentKimberly A Struble, Kellie Schoolar Reynolds
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2022
Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAsXing Jing, Vikram Arya, Kellie Schoolar Reynolds, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|February 9, 2018
Breaking Down Barriers to Effective Patient CarePeter H O'Donnell, Kellie Schoolar Reynolds
Current Opinion in HIV and AIDS|April 18, 2009
A regulatory perspective on the role of drug interactions in antiretroviral drug developmentKimberly A Struble, Kellie Schoolar Reynolds
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 4, 2022
Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAsXing Jing, Vikram Arya, Kellie Schoolar Reynolds, et al.
Pageof 1